Latest filings (excl ownership)
6-K
Report of Foreign Private Issuer
6 Mar 24
20-F
2023 FY
Annual report (foreign)
6 Mar 24
6-K
Report of Foreign Private Issuer
28 Feb 24
6-K
Report of Foreign Private Issuer
28 Dec 23
6-K
Report of Foreign Private Issuer
6 Dec 23
6-K/A
Notice of Annual General Meeting of Shareholders
13 Nov 23
6-K
Notice of Annual General Meeting of Shareholders
13 Nov 23
6-K
Report of Foreign Private Issuer
13 Nov 23
6-K
Report of Foreign Private Issuer
8 Nov 23
6-K
Report of Foreign Private Issuer
16 Oct 23
6-K
Kamada Provides Corporate Update on its Israel Operations
10 Oct 23
EFFECT
Notice of effectiveness
15 Sep 23
CORRESP
Correspondence with SEC
13 Sep 23
UPLOAD
Letter from SEC
12 Sep 23
F-3
Shelf registration (foreign)
11 Sep 23
6-K
Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds
30 Aug 23
6-K
Report of Foreign Private Issuer
16 Aug 23
6-K
Report of Foreign Private Issuer
9 Aug 23
6-K
Notice of Extraordinary General Meeting of Shareholders
13 Jul 23
6-K
Report of Foreign Private Issuer
12 Jul 23
6-K/A
Current report (foreign) (amended)
24 May 23
6-K
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates
24 May 23
6-K
Report of Foreign Private Issuer
24 May 23
6-K
Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds
24 May 23
6-K
Report of Foreign Private Issuer
17 May 23
6-K
Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland
16 May 23
6-K
Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM® at the Company’s Facility in Israel
3 May 23
6-K
Kamada Issues 2023 CEO Letter to Shareholders
15 Mar 23
6-K
Report of Foreign Private Issuer
15 Mar 23
20-F
2022 FY
Annual report (foreign)
15 Mar 23
6-K
Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, and Provides 2023 Guidance Representing Significant Profitability Growth
15 Mar 23
6-K
Report of Foreign Private Issuer
9 Mar 23
6-K
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
4 Jan 23
6-K
Report of Foreign Private Issuer
22 Dec 22
6-K
Kamada Announces Planned Transition of Chief Financial Officer
19 Dec 22
6-K
Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
22 Nov 22
6-K/A
Current report (foreign) (amended)
17 Nov 22
6-K
Report of Foreign Private Issuer
16 Nov 22
6-K
Notice of Annual General Meeting of Shareholders
8 Nov 22
6-K
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT
7 Nov 22
Latest ownership filings
SC 13G/A
Gov Financial Holdings Ltd.
14 Feb 24
SC 13G/A
Phoenix Holdings Ltd.
12 Feb 24
SC 13G/A
Phoenix Holdings Ltd.
28 Dec 23
SC 13G/A
Phoenix Holdings Ltd.
19 Dec 23
SC 13D/A
DAVIDI ISHAY
7 Sep 23
SC 13D/A
DAVIDI ISHAY
24 May 23
SC 13G/A
Phoenix Holdings Ltd.
14 Feb 23
SC 13G/A
Phoenix Holdings Ltd.
7 Feb 22
SC 13G/A
Phoenix Holdings Ltd.
9 Nov 21
SC 13G/A
Hahn Jonathan
16 Feb 21
SC 13G/A
Gov Financial Holdings Ltd.
11 Feb 21
SC 13G/A
Phoenix Holdings Ltd.
11 Aug 20
SC 13G/A
Phoenix Holdings Ltd.
29 Jul 20
SC 13D/A
DAVIDI ISHAY
20 May 20
SC 13G/A
Phoenix Holdings Ltd.
27 Apr 20
SC 13G/A
Kamada LTD
24 Feb 20
SC 13G/A
Kamada LTD
18 Feb 20
SC 13G/A
Beneficial ownership report (amended)
18 Feb 20
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G/A
Beneficial ownership report (amended)
12 Feb 20
SC 13D/A
Kamada LTD
29 Jan 20
SC 13D/A
Kamada LTD
21 Jan 20
SC 13D/A
Kamada LTD
2 Dec 19
SC 13D
Kamada LTD
27 Nov 19
SC 13G/A
Kamada LTD
14 Feb 19
SC 13G/A
Kamada LTD
14 Feb 19
SC 13G/A
Kamada LTD
14 Feb 19
SC 13G/A
Kamada LTD
7 Feb 19
SC 13G/A
Kamada LTD
20 Feb 18
SC 13G/A
Kamada LTD
15 Feb 18
SC 13G/A
Kamada LTD
14 Feb 18
SC 13G/A
Kamada LTD
31 Jan 18
SC 13G
Kamada LTD
8 Jan 18
SC 13D/A
Beneficial ownership report (amended)
13 Nov 17
SC 13D/A
Beneficial ownership report (amended)
6 Nov 17
SC 13D
Kamada LTD
13 Sep 17
SC 13G/A
Kamada LTD
23 Aug 17
SC 13G
Kamada LTD
15 Feb 17
SC 13G/A
Kamada LTD
15 Feb 17